TipRanks

TipRanks

Benzinga Contributor

Analysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Acrivon Therapeutics, Inc. (ACRV)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on VistaGen Therapeutics (VTGN – Research Report) and A...
Analysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Acrivon Therapeutics, Inc. (ACRV)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on VistaGen Therapeutics (VTGN – Research Report) and A...
Ohmyhome Limited: Strong Buy Recommendation on Robust Growth and Strategic Expansion
Maxim Group analyst Allen Klee reiterated a Buy rating on Ohmyhome Limited (OMH – Research Report) yesterday and set a price target of $3.00. Allen...
Ohmyhome Limited: Strong Buy Recommendation on Robust Growth and Strategic Expansion
Maxim Group analyst Allen Klee reiterated a Buy rating on Ohmyhome Limited (OMH – Research Report) yesterday and set a price target of $3.00. Allen...
Maxim Group Sticks to Its Buy Rating for Cullen/Frost Bankers (CFR)
In a report released yesterday, Michael Diana from Maxim Group reiterated a Buy rating on Cullen/Frost Bankers (CFR – Research Report). The company...
Maxim Group Sticks to Its Buy Rating for Cullen/Frost Bankers (CFR)
In a report released yesterday, Michael Diana from Maxim Group reiterated a Buy rating on Cullen/Frost Bankers (CFR – Research Report). The company...
SQL Technologies Poised for Growth as Smart Home Innovator with Strong Patent Portfolio and Strategic Expansion
Jack Vander Aarde, an analyst from Maxim Group, has initiated a new Buy rating on SQL Technologies (SKYX). Jack Vander Aarde's rating is based on t...
SQL Technologies Poised for Growth as Smart Home Innovator with Strong Patent Portfolio and Strategic Expansion
Jack Vander Aarde, an analyst from Maxim Group, has initiated a new Buy rating on SQL Technologies (SKYX). Jack Vander Aarde's rating is based on t...
Buy Rating Affirmed for Capricor Therapeutics Amidst Positive FDA Discussions and Clinical Advancements
Capricor Therapeutics (CAPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCa...
Buy Rating Affirmed for Capricor Therapeutics Amidst Positive FDA Discussions and Clinical Advancements
Capricor Therapeutics (CAPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCa...
Microsoft and Alphabet: Top Analysts Choose the Best AI Stocks to Buy After Earnings
Investors got a scare this week after softer-than-expected earnings from Meta cast some doubt on the staying power of the AI boom. But Thursday's r...
Microsoft and Alphabet: Top Analysts Choose the Best AI Stocks to Buy After Earnings
Investors got a scare this week after softer-than-expected earnings from Meta cast some doubt on the staying power of the AI boom. But Thursday's r...
Navigating the Unknown: Banco Latinoamericano's High-Stakes Innovation Journey to Meet Customer Expectations
Banco Latinoamericano De Comercio (BLX) has disclosed a new risk, in the Competition category. Banco Latinoamericano De Comercio faces substantial ...
Navigating the Unknown: Banco Latinoamericano's High-Stakes Innovation Journey to Meet Customer Expectations
Banco Latinoamericano De Comercio (BLX) has disclosed a new risk, in the Competition category. Banco Latinoamericano De Comercio faces substantial ...
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Accolade, Inc. (ACCD) has disclosed a new risk, in the Regulation category. Accolade, Inc. faces significant business risk as it integrates AI into...
Accolade, Inc. at a Crossroads: Navigating Regulatory Risks in AI Integration
Accolade, Inc. (ACCD) has disclosed a new risk, in the Regulation category. Accolade, Inc. faces significant business risk as it integrates AI into...
Intercorp's Risk Management Strategy: Balancing Predictive Strength with Unseen Perils
Intercorp Financial Services (IFS) has disclosed a new risk, in the Corporate Activity and Growth category. Intercorp Financial Services aims to em...
Intercorp's Risk Management Strategy: Balancing Predictive Strength with Unseen Perils
Intercorp Financial Services (IFS) has disclosed a new risk, in the Corporate Activity and Growth category. Intercorp Financial Services aims to em...
Chubb Ltd Invests $316 Million in Self-Confidence: A Strategic Move with 1.5 Million Shares Repurchased
Chubb Ltd (CB) has disclosed a new risk, in the Debt & Financing category. Chubb Ltd's repurchase of equity securities during the first quarter of ...
Chubb Ltd Invests $316 Million in Self-Confidence: A Strategic Move with 1.5 Million Shares Repurchased
Chubb Ltd (CB) has disclosed a new risk, in the Debt & Financing category. Chubb Ltd's repurchase of equity securities during the first quarter of ...